{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-seasonal-influenza/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"01093f11-51ae-50df-8509-ec07849034a9","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field a3854ab9-579f-4c06-81d1-751d3d3a10f0 --><h2>Changes</h2><!-- end field a3854ab9-579f-4c06-81d1-751d3d3a10f0 -->","summary":null,"htmlStringContent":"<!-- begin item 61460341-9954-4683-aece-7ac1d80fed52 --><!-- begin field ce147f9a-2f95-434d-bac0-80d26d9534ec --><p><strong>December 2020</strong> — minor update. Information added to reflect the authorization of the use of the recombinant quadrivalent vaccine (QIVr) in the 2020/2021 immunization programme.</p><p><strong>August 2020</strong> — minor update. Eligibility for seasonal influenza immunizations updated in line with the updated 2020/2021 immunization programme. Details of available vaccines have also been updated in line with the World Health Organization recommendations and Public Health England information.  </p><p><strong>July 2020</strong> — minor update. Eligibility for seasonal influenza immunizations updated in line with the 2020/2021 immunization programme.</p><p><strong>January 2020</strong> — minor update. Quality standards added.</p><p><strong>September 2019 </strong>— minor update. Information added to reflect the 2019/2020 immunization programme including eligibility, vaccination availability and suitability.</p><p><strong>September 2018 </strong>— minor update. Information added to reflect the 2018/2019 immunization programme regarding eligibility. </p><p><strong>May 2018 </strong>— reviewed. A literature search was conducted in May 2018 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of this topic. The topic has undergone restructuring. No major changes to the recommendations have been made.</p><!-- end field ce147f9a-2f95-434d-bac0-80d26d9534ec --><!-- end item 61460341-9954-4683-aece-7ac1d80fed52 -->","topic":{"id":"9b6b800a-723f-5d15-a3b3-e02063fe3c99","topicId":"92586dea-3104-4e8a-bc44-03b987a2edbd","topicName":"Immunizations - seasonal influenza","slug":"immunizations-seasonal-influenza","lastRevised":"Last revised in December 2020","chapters":[{"id":"d76923a5-5c5f-5a11-a814-a5cb25677ea4","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"2ba8fbd2-e67d-5358-81f0-924960cf0be5","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"732d4482-9024-5590-a7eb-2302afbfdfb4","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"01093f11-51ae-50df-8509-ec07849034a9","slug":"changes","fullItemName":"Changes"},{"id":"acbbda46-e0ae-5671-bacb-2a6a13a3c48c","slug":"update","fullItemName":"Update"}]},{"id":"2076ad4b-733a-531b-a566-ab63793ca4c5","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"abdfa463-1f9a-5c6c-97e5-0c8cf32a1245","slug":"goals","fullItemName":"Goals"},{"id":"8771bc09-4770-5b11-9629-ba462c397ae6","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"cabc3c03-ff36-515a-b973-f91f2f073567","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7a42bc64-dd67-5232-9220-bdf56acb5c4c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6334087f-5e9d-5ae0-b123-0988f7171dc7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b60207bc-ceae-5d6f-abb8-1f6bc080bffc","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"4c8ddd5f-4fd9-5971-b539-806fa0341ca6","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2ecf8cae-934e-53ec-8216-de939261798a","slug":"definition-of-influenza","fullItemName":"Definition of influenza"},{"id":"1340565d-3167-5013-892b-f55f963e594b","slug":"influenza-vaccines","fullItemName":"Influenza vaccines"}]},{"id":"c24a89e0-d8d7-53a8-b2d4-4187af763e27","fullItemName":"Management","slug":"management","subChapters":[{"id":"ccf35d76-5a70-5707-9d61-52ca23e54e91","slug":"immunizations-seasonal-influenza","fullItemName":"Scenario: Immunizations - seasonal influenza"}]},{"id":"768b3628-e7db-58a1-8684-aead55533454","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"d99a53cc-c2a9-507d-b699-09ee1f7cc101","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"863e5e76-1aca-5995-a6e9-d1a5fb5014a9","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0f50bd98-0307-58c8-a950-f50210eac7fa","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"203d2edb-0764-5bf9-b609-e73840389249","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"c5ecb68c-3006-54b8-8490-50ca223f01c9","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a537af28-d7fb-50c5-8510-d92fbf917777","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"195ebe32-2726-5fb9-a629-dd9e743c180b","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"732d4482-9024-5590-a7eb-2302afbfdfb4","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"ef2e1489-ddf5-5020-8db9-d48dbf61e30e","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field aa798ea0-cc18-40bb-8caa-c85c52a15e1f --><h3>Previous changes</h3><!-- end field aa798ea0-cc18-40bb-8caa-c85c52a15e1f -->","summary":null,"htmlStringContent":"<!-- begin item 66dc3ec8-0286-4deb-a750-8d8ac619048a --><!-- begin field 48aa8687-2103-4e2a-b51c-3666ae4004fa --><p><strong>August 2017</strong> — minor update. Information added to reflect the 2017/18 immunization programme regarding eligibility. </p><p><strong>January 2017</strong> — minor update. Information added on contraindication to Fluenz Tetra<sup>®</sup> nasal spray for anyone with severe allergic reaction to egg as per the manufacturer's summary of product characteristics.</p><p><strong>November 2016</strong> — minor update. Information from the Public Health England (PHE) document <em>Immunisation against infectious disease — The Green Book </em>has been added to clarify the benefits of quadrivalent vaccines. </p><p><strong>September 2016 </strong>— reviewed. A literature search was conducted in September 2016 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials since the last revision of this topic. The recommendations on the clinical risk groups eligible for annual influenza immunization have been updated to include people with morbid obesity; the information on the extension of the national childhood influenza immunization programme has been updated to include children of appropriate age for school years 1, 2, and 3; and the information on the management of children and adults with egg allergy have all been updated in line with the chapter on Influenza in the Public Health England (PHE) document <em>Immunisation against infectious disease — 'The Green Book</em>' for the 2016/2017 influenza season. The information on available vaccines has been updated in line with PHE. The topic has also undergone minor restructuring.</p><p><strong>February 2015 </strong>— minor update. Addition of people with learning disabilities to the table in at risk groups list.</p><p><strong>December 2014 </strong>— minor update. Citation updated regarding administration of influenza vaccines and porcine gelatine in multi-faith groups.</p><p><strong>September 2014 </strong>—<strong> </strong>revised to include updated guidance from the Department of Health's <em>Immunization against infectious disease — 'The Green Book' </em>chapter 19, <em>Influenza</em> for the 2014/2015 seasonal influenza vaccination programme.</p><p><strong>August 2014 </strong>— minor update. Minor typographical error corrected in the evidence section on the use of influenza vaccines in healthy adults.</p><p><strong>October 2013 </strong>— revised to include updated guidance from the Department of Health's <em>Immunization against infectious disease — 'The Green Book' </em>chapter 19, <em>Influenza</em> (updated in September 2013) for the 2013/2014 seasonal influenza vaccination programme.</p><p><strong>August 2013 </strong>— minor update. The text has been updated to reflect new recommendations from Public Health England regarding seasonal vaccine for children aged two to three years old.</p><p><strong>June 2013 </strong>— minor update. The 2013 QOF options for local implementation have been added to this topic.</p><p><strong>September 2012 </strong>—<strong> </strong>revised to include updated guidance from the Department of Health's <em>Immunization against infectious disease — 'The Green Book' </em>chapter 19, <em>Influenza</em> (updated in August 2012) for the 2012/2013 seasonal influenza vaccination programme.</p><p><strong>March 2012 </strong>— minor update. The 2012/2013 QOF indicators have been added to this topic. Issued in April 2012.</p><p><strong>February 2012 </strong>—<strong> </strong>minor update to include further information about excipients in currently available vaccines. Issued in March 2012.</p><p><strong>October 2011 </strong>—<strong> </strong>minor update to reflect the updated guidance on egg allergy from the Department of Health's <em>Immunization against infectious disease — 'The Green Book' </em>chapter 19, <em>Influenza</em> (updated in July 2011) for the 2011/2012 seasonal influenza vaccination programme. Issued in October 2011.</p><p><strong>September 2011 </strong>—<strong> </strong>revised to include updated guidance from the Department of Health's <em>Immunization against infectious disease — 'The Green Book' </em>chapter 19, <em>Influenza</em> (updated in July 2011) for the 2011/2012 seasonal influenza vaccination programme, and new recommendations from the Chief Medical Officer (2011). This CKS topic gives recommendations for the 2011/2012 influenza season only. Issued in September 2011.</p><p><strong>May 2011 </strong>— minor update. The 2011/2012 QOF indicators have been added to this topic in line with the BMA and NHS Employers document (2011). Issued in June 2011.</p><p><strong>February 2011 </strong>— minor update. The Chief Medical Officer has clarified that seasonal influenza vaccine should be offered to all pregnant women, regardless of whether they have received a previous dose of H1N1 swine influenza vaccine. Issued in February 2011.</p><p><strong>October 2010 </strong>— minor update. The Ministry of Health of Saudi Arabia now recommends that pilgrims for the Hajj and Umrah season of 1431 (2010) receive seasonal influenza vaccine, in line with the NaTHNaC (2010) publication. Issued in November 2010.</p><p><strong>September 2010 </strong>— updated to include the new recommendations from the Department of Health for the 2010/11 seasonal influenza vaccination programme. Issued in September 2010.</p><p><strong>August 2010 </strong>— minor update. The Department of Health (2010) has advised that Enzira<sup>®</sup>and CSL Biotherapies generic influenza vaccine should not be used to vaccinate children under the age of 5 years. An alternative vaccine should be used in this age group. Issued in August 2010.</p><p><strong>April to July 2009</strong> — converted from CKS guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. A new recommendation to offer influenza immunization to poultry workers has been included.</p><p><strong>June 2009 </strong>— minor update. Additional swine flu links added. Issued in June 2009.</p><p><strong>May 2009 </strong>— minor update. Links to information sources regarding 'swine flu' have been added to <em>Have I got the right topic? </em>section<em>. </em>Issued in June 2009.</p><p><strong>January 2008 </strong>— minor update. Influenza split virion vaccine is no longer a black triangle product. Prescription updated. Issued in January 2008.</p><p><strong>April to June 2006 </strong>— written. Validated in September 2006 and issued in October 2006. This is a new guidance and replaces the relevant sections that used to be in the CKS topic on <em>Influenza</em>. The information and recommendations have been updated following a full literature review. A more detailed evidence section to support the recommendations has been included.</p><!-- end field 48aa8687-2103-4e2a-b51c-3666ae4004fa --><!-- end item 66dc3ec8-0286-4deb-a750-8d8ac619048a -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}